Frontlight ResearchEarly access
CompletedNo phase
Microcirculation and Coagulopathy in Sepsis
Key facts
- Who runs it
- Università Politecnica delle Marche
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 1 Jun 2023
- Ended
- 30 Jun 2025
- Type of study
- Observational
- Record updated
- 11 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- adult (>18 years of age)
- sepsis or septic shock
Who cannot take part
- concurrent use of therapeutic anticoagulation or thrombolytic agents
- sepsis for more than 24 hours
- pre-existing coagulopathy
- factors impeding the sublingual microvascular assessment
- pregnancy
- inability to obtain informed consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Sepsis-induced coagulopathy (SIC) and microvascular dysfunction are hallmark features of sepsis, yet their longitudinal relationship remains poorly understood. The aim of this study is to investigate the interplay between sublingual microcirculation, endothelial damage, peripheral tissue oxygenation and coagulation parameters in patients with sepsis.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Relationship Between Microcirculatory Alterations and Coagulopathy in Sepsis: Prospective Observational Study.
- Record updated
- 11 February 2026